“…Although an «-thalassemia-2 trait cannot be completely ruled out in the absence of data about gene mapping and mRNA quantitation, nevertheless, on the grounds of both complete absence of even minimal hematological changes and presence of balanced «/total ft chain syn thesis ratios, a concurrent «-thalassemia, which is known to influence the level of this abnormal hemoglobin [9], seems unlikely to occur in the present Hb G San José carriers. Furthermore, it seems very unlikely that the GAG -< • GGG mutation underlying the Glu -*■ Gly substitution is responsible per se for a slow rate of translation of the abnormal j1 chain mRNA, at least as far as polypeptide chain elongation and release from poly somes are concerned, since the GGG codon (coding for ft 46 Gly) is already present in the ft mRNA and a similar codon substitu tion is responsible for Hb Alberta [5] which represents 44.9% of the total Hb.…”